16 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
volunteers. The Company expects to share additional results from this EEG study at the upcoming American Epilepsy Society (AES) medical meeting in December … BHV-7000 at the American Epilepsy Society Annual Meeting in December: The Company expects to present complete results from its EEG study with BHV
8-K
EX-99.1
BHVN
Biohaven Ltd.
27 Sep 23
Regulation FD Disclosure
6:58am
Vehicle 0.3 1 3 10 30 0 50 100 150 200 250 BHV-7000 (mg/kg) Presented at 2023 American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting … American Epilepsy Society Meeting 2019, Abstract #3.31. Poster presented November 25, 2019. AE, adverse event; ASM, anti-seizure medication; CNS
8-K
EX-99.1
sf04t
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
424B4
ulto wc5r8
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
k6sj1m951x1 emnd
20 Oct 22
IPO registration (amended)
10:00am
S-1
ykr29
18 Oct 22
IPO registration
4:03pm
DRS
oxpgw 9hdotrp
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
oygbp2e
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
j71my
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
1ty0va0
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
xfg6g
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
i6jk9wdwoj
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
fxx 1ogus
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next